SAMHD1 Gene

SAM And HD Domain Containing Deoxynucleoside Triphosphate Triphosphohydrolase 1 (SAMHD1) is a gene involved in antiviral restriction that has been studied in relation to immune function, metabolism, and chronic illness. Variants in SAMHD1 may influence how the body responds to infection, inflammation, and long-term recovery.

This page is for educational and informational purposes only. Not a diagnostic tool. Always consult a qualified healthcare provider.

What is the SAMHD1 gene?

SAMHD1 encodes sam and hd domain containing deoxynucleoside triphosphate triphosphohydrolase 1, a protein involved in antiviral restriction. It belongs to the Innate Immunity category and is part of the Innate Immunity & Interferons biological cluster. SAMHD1 is a dNTPase that restricts HIV-1 and other retroviruses by depleting the dNTP pool needed for reverse transcription. Loss-of-function mutations cause Aicardi-Goutières syndrome type 5, a type I interferonopathy.

Biological role and pathway

SAMHD1 is involved in the antiviral restriction pathway, which plays a central role in regulating physiological processes relevant to immune defence, cellular energy, and systemic homeostasis. Genes within the Innate Immunity & Interferons cluster work together to maintain balanced function across interconnected biological systems.

Variants in genes within this pathway may influence an individual's predisposition to altered function in these systems — particularly under conditions of physiological stress such as viral infection or prolonged illness.

SAMHD1 and Long COVID / ME-CFS research

SAMHD1 restricts LINE-1 retrotransposon activity and prevents cytosolic DNA accumulation. Like TREX1, SAMHD1 prevents cGAS-STING activation by endogenous nucleic acids; variants may contribute to the chronic interferon state and DNA damage response activation in Long COVID.

This information is based on published research and does not constitute medical advice. See references below.

Known genetic variants

The following variants (SNPs) in the SAMHD1 gene have been studied in relation to innate immunity and chronic illness. Each variant represents a single nucleotide position where individuals may carry different alleles.

Conditions studied in relation to SAMHD1

Research into SAMHD1 variants has explored associations with the following conditions. These are areas of scientific investigation and do not imply that SAMHD1 causes or treats any condition.

Genetic insights from DNA data

Consumer DNA files from 23andMe, AncestryDNA, and MyHeritage contain raw SNP data. When you upload your file to ChronicDNA, the analysis engine checks your genotype against a curated panel of 80+ genes selected for their relevance to Long COVID, ME/CFS, and connected biological pathways - some of which may include SAMHD1 and related genes in the innate immunity & interferons pathway.

The report is educational - it explains which variants you carry, what the research says about them, and how they fit into the biological pathways most relevant to chronic illness. Results are presented in plain English with appropriate scientific context, no medical jargon, no scare tactics. All results should be discussed with a qualified healthcare provider.

Related genes in the Innate Immunity & Interferons pathway

SAMHD1 does not act in isolation. The following genes are functionally related and may be analysed together for a more complete picture of your genetic predispositions.

Frequently asked questions

What is the SAMHD1 gene and what does it do?

SAMHD1 (SAM And HD Domain Containing Deoxynucleoside Triphosphate Triphosphohydrolase 1) is involved in antiviral restriction. SAMHD1 is a dNTPase that restricts HIV-1 and other retroviruses by depleting the dNTP pool needed for reverse transcription. Loss-of-function mutations cause Aicardi-Goutières syndrome type 5, a type I interferonopathy.

How may SAMHD1 gene variants relate to Long COVID or ME/CFS?

SAMHD1 restricts LINE-1 retrotransposon activity and prevents cytosolic DNA accumulation. Like TREX1, SAMHD1 prevents cGAS-STING activation by endogenous nucleic acids; variants may contribute to the chronic interferon state and DNA damage response activation in Long COVID.

Can a DNA test reveal information about my SAMHD1 gene?

Consumer DNA data from 23andMe, AncestryDNA, and MyHeritage includes SNP variants for many genes. ChronicDNA analyses your raw DNA file and reports on variants that have been studied in relation to chronic illness, immune function, and metabolism. This is not a diagnostic service — results are informational and educational only.

Explore your SAMHD1 genetic insights

Upload your DNA data from 23andMe, AncestryDNA, or MyHeritage and receive a personalised report covering >80 genes relevant to Long COVID and ME/CFS.

Get Your Personalised DNA Report

Informational and educational only · Not a diagnostic tool · GDPR compliant

References

The following publications were used in compiling the research context for SAMHD1. This is not an exhaustive literature review.

  • [1]PMID: 25416949
  • [2]Nature Genetics
  • [3]Cell Host & Microbe